Skip to main content

Dihexa: Best Telehealth Providers for Cognitive Health & Brain Function (2026)

A small molecule peptidomimetic derived from angiotensin IV that potently activates the HGF/Met signaling system. Animal studies show cognitive enhancement orders of magnitude more potent than BDNF. Studied for Alzheimer's disease and cognitive decline.

Sarah Chen
Sarah ChenLead Health Editor
Dr. James Okafor, PharmDReviewed by Dr. James Okafor, PharmDPharmD
Updated January 15, 2025
Fact CheckedClinically Reviewed
Updated January 2025 — may be outdated
CognitiveOral or transdermalPrescription Required

Dihexa at a Glance

Category

Cognitive Health & Brain Function

Administration

Oral or transdermal

Telehealth Providers

3 compared

Price Range

$60 – $260/mo

Typical Dose

5-35mg per week

Frequency

Divided across the week (oral/transdermal)

Protocol Duration

2-4 week cycles

Prescription

Required

Research highlight: Dihexa is described as 10 million times more potent than BDNF for promoting synaptogenesis in animal models, activating the HGF/Met signaling pathway critical for memory consolidation and new synaptic connection formation.

What is Dihexa Used For?

Also known as: PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide

  • Cognitive enhancement
  • Memory improvement
  • Neuroprotection
  • Alzheimer's research

How Dihexa Works

Dihexa (PNB-0408) is a small peptidomimetic derived from angiotensin IV that activates the HGF/Met (hepatocyte growth factor/c-Met receptor) signaling pathway in the brain. HGF/Met signaling promotes synaptogenesis — the formation of new synaptic connections between neurons — which is critical for memory consolidation and cognitive function. Animal studies demonstrate cognitive enhancement orders of magnitude more potent than BDNF itself. Dihexa crosses the blood-brain barrier efficiently via oral and transdermal routes.

DihexaDosing & Administration

Typical Dose5-35mg per week
FrequencyDivided across the week (oral/transdermal)
Protocol Duration2-4 week cycles
RouteOral or transdermal

Dosing information is for educational purposes only. Your prescribing physician will determine the appropriate dose based on your medical history and treatment goals.

What to Expect from Dihexa

Cognitive effects are typically reported within 1–3 days of use — improved memory recall, enhanced verbal fluency, and increased mental clarity. Effects may be dose-dependent and cumulative with regular use over 2–4 weeks. Because it promotes synaptic plasticity, cognitive gains may persist beyond the active dosing period. Individual variation is significant.

Who Should Consider Dihexa?

  • Memory improvement and cognitive decline
  • Alzheimer's disease research participants
  • Advanced nootropic users seeking potent cognitive enhancement
  • Those prioritizing synaptogenesis and neural plasticity

Dihexa Side Effects

  • Overstimulation or anxiety at high doses
  • Headache
  • Irritability or agitation
  • Insomnia if taken late in the day
  • Long-term safety profile not established in humans

This is not a complete list of side effects. Always consult your prescribing physician before starting Dihexa.

3 Telehealth Providers Offering Dihexa

Sorted by lowest price. All providers require a prescription from a licensed physician.

ProviderPriceDoseRatingConsultationLab Testing
Amino Asylum

United States

$60/one-timeNasal or topical3.8/5Async TelehealthNot included
Defy Medical

Tampa, FL

$200/monthlyStandard protocol4.1/5Video TelehealthIncluded
TruLife Health

Scottsdale, AZ

$260/monthlyStandard protocol4.1/5Video TelehealthIncluded

How to Choose the Best Telehealth Provider for Cognitive Peptides

Cognitive enhancement peptides affect brain chemistry and neural function. Careful provider selection is critical for safety and results.

Neurological Screening

Before prescribing cognitive peptides, providers should screen for neurological conditions, medication interactions (especially MAOIs, SSRIs), and contraindications. Brain-active compounds require more thorough evaluation than peripheral peptides.

Peptide Selection Expertise

Cognitive peptides have distinct profiles — Semax for acute focus (BDNF pathway), Selank for anxiolytic cognition (GABA pathway), Dihexa for memory (HGF/Met pathway), P21 for neurogenesis (CNTF pathway). Providers should match the peptide to your specific cognitive goal.

Compounding Pharmacy Specialization

Intranasal peptides require precise formulation and sterility standards. Verify your provider's compounding pharmacy has experience with nasal spray preparations and follows appropriate sterility protocols.

Baseline Cognitive Assessment

The best providers establish a cognitive baseline (through testing, questionnaires, or detailed history) so improvements can be objectively tracked — not just subjectively reported.

Stacking Safety

Cognitive peptides are frequently stacked (Semax + Selank is common). Providers should have experience managing peptide combinations that affect serotonin, dopamine, and GABA systems to avoid adverse interactions.

Cycling and Duration Guidance

Most cognitive peptides are used in 2–4 week cycles. Providers should offer clear guidance on cycle length, when to take breaks, and how to assess whether to continue or adjust the protocol.

Frequently Asked Questions About Dihexa

How potent is Dihexa compared to other nootropics?

Dihexa is described in its original research (Joseph et al., WSU) as being 10 million times more potent than BDNF in promoting synaptogenesis in animal models. In terms of practical cognitive enhancement, users report it as among the most noticeable single-compound nootropics — more so than racetams, modafinil, or most peptide nootropics.

Can Dihexa be taken orally?

Yes — unlike most peptides, Dihexa is a peptidomimetic (a non-peptide compound that mimics a peptide's activity) with favorable oral bioavailability and ability to cross the blood-brain barrier. It is also used transdermally. Oral dosing is typically 5–35mg per week (not daily — due to long duration of action and potency).

Is Dihexa being developed for Alzheimer's disease?

Dihexa was originally developed at Washington State University with Alzheimer's disease in mind — HGF/Met signaling loss is a feature of AD pathology. It has shown memory restoration in aged and Alzheimer's mouse models. No human clinical trials are published as of 2025, but it is of significant research interest.

What are the risks of promoting synaptogenesis?

Promoting synaptogenesis theoretically could enhance existing connections non-selectively, including those encoding fear, trauma, or maladaptive patterns. There are also theoretical concerns about excessive synaptic growth in oncological contexts. These theoretical risks have not materialized in animal studies, but long-term human safety data is absent. Caution and physician supervision are warranted.